Trends, Outcomes, and Readmissions Among Left Ventricular Assist Device Recipients with Acute Kidney Injury Requiring Hemodialysis.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 14 6 2019
medline: 18 11 2020
entrez: 14 6 2019
Statut: ppublish

Résumé

Although renal function may improve after left ventricular assist devices (LVAD) implantation, acute kidney injury (AKI) requiring hemodialysis (HD) therapy can occur postoperatively. We used data from the National Readmissions Database to calculate annual rates of in-hospital outcomes and readmissions among patients who underwent implantation and developed acute kidney injury (AKI) requiring hemodialysis (HD) for years 2012-2015. We identified 178 (weighted 469) patients with AKI requiring HD after LVAD implantation. In-hospital mortality was significantly higher among LVAD recipients who required HD for AKI compared with those who did not (42.38% vs. 8.38%, p < 0.001). Rates of in-hospital mortality (from 52.1% in 2012 to 33.9% in 2014, p = 0.046) and length of stay (from 60.3 days in 2012 to 47.1 days in 2014, p = 0.003) decreased significantly, whereas there was a trend toward reduced hospital cost (from $320,414 in 2012 to $267,285 in 2014, p = 0.076) during the study period. However, postoperative bleeding increased significantly (p = 0.01). Acute kidney injury requiring HD after implantation was not associated with significantly higher rates of readmissions compared with LVAD recipients without AKI on HD, after adjustment for clinical and hospital characteristics (41.4% vs. 30.5%; odds ratio 1.28; 95% confidence interval [CI]: 0.85-1.95; P = 0.239). However, 5.42% of these patients required maintenance hemodialysis in readmissions. In-hospital mortality and length of stay are decreasing but remain unacceptably high in patients requiring HD for AKI after LVAD implantation but remain higher than LVAD recipients without AKI on HD. A minority of these patients who survive hospital discharge require maintenance hemodialysis.

Identifiants

pubmed: 31192850
doi: 10.1097/MAT.0000000000001036
pii: 00002480-202005000-00009
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-512

Références

Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant 2017.36: 1080–1086.
Miller LW, Pagani FD, Russell SD, et al.; HeartMate II Clinical Investigators: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007.357: 885–896.
Aaronson KD, Slaughter MS, Miller LW, et al.; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators: Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012.125: 3191–3200.
Estep JD, Starling RC, Horstmanshof DA, et al.; ROADMAP Study Investigators: Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Results from the ROADMAP study. J Am Coll Cardiol 2015.66: 1747–1761.
Shah KB, Starling RC, Rogers JG, et al.; ROADMAP Investigators: Left ventricular assist devices versus medical management in ambulatory heart failure patients: an analysis of INTERMACS profiles 4 and 5 to 7 from the ROADMAP study. J Heart Lung Transplant 2018.37: 706–714.
Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 2007.116(suppl 11): I8–I15.
Hasin T, Topilsky Y, Schirger JA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 2012.59: 26–36.
Hasin T, Grupper A, Dillon JJ, et al. Early gains in renal function following implantation of HeartMate II left ventricular assist devices may not persist to one year. ASAIO J 2017.63: 401–407.
Ross DW, Stevens GR, Wanchoo R, et al. Left ventricular assist devices and the kidney. Clin J Am Soc Nephrol 2018.13: 348–355.
Topkara VK, Coromilas EJ, Garan AR, et al. Preoperative proteinuria and reduced glomerular filtration rate predicts renal replacement therapy in patients supported with continuous-flow left ventricular assist devices. Circ Heart Fail 2016.9: e002897.
Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006.25: 404–408.
Healthcare Cost and Utilization Project (HCUP): NRD Overview. 2018. Rockville, MD, Agency for Healthcare Research and Quality, Cited October 2018. Available at: www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed February 2019.
Healthcare Cost and Utilization Project (HCUP): Overview of the National (Nationwide) Inpatient Sample (NIS). 2018. Rockville, MD, Agency for Healthcare Research and Quality, Cited August 2018, September 2018. Available at: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed February 2019.
U.S. Bureau of Labor Statistics, Consumer Price Index for All Urban Consumers: Hospital and related services [CUSR0000SEMD], retrieved from FRED, Federal Reserve Bank of St. Louis; January 30, 2018 [cited january, 2018]. Available at: https://fred.stlouisfed.org/series/CUSR0000SEMD.
Barrett M, C. R., Houchens R, Heslin K, Moles E, Coenen N. Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2017 National Healthcare Quality and Disparities Report (QDR). HCUP Methods Series Report # 2018-01. May, 2018. U.S. Agency for Healthcare Research and Quality. 2018. Available at: http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp. [May, 2018 August, 2018]
Khera R, Angraal S, Couch T, et al. Adherence to methodological standards in research using the national inpatient sample. JAMA 2017.318: 2011–2018.
Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail 2009.15: 874–881.
Brisco MA, Kimmel SE, Coca SG, et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail 2014.7: 68–75.
James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995.92(suppl 9): II191–II195.
James KB, McCarthy PM, Jaalouk S, et al. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996.93: 1515–1519.
Quader MA, Kumar D, Shah KB, Fatani YI, Katlaps G, Kasirajan V. Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices. Hemodial Int 2014.18: 205–209.
Calenda BW, Smietana J, Casagrande L. Long-term hemodialysis via arteriovenous fistula in patients with continuous-flow left ventricular assist devices. Artif Organs 2016.40: 712.
Schaefers JF, Ertmer C. Native arteriovenous fistula placement in three patients after implantation of a left ventricular assist device with non-pulsatile blood flow. Hemodial Int 2017.21: E54–E57.
Briasoulis A, Inampudi C, Akintoye E, Adegbala O, Alvarez P, Bhama J. Trends in utilization, mortality, major complications, and cost after left ventricular assist device implantation in the United States (2009 to 2014). Am J Cardiol 2018.121: 1214–1218.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH